Status:
UNKNOWN
Modification of Cue Reactivity by Neurofeedback in Human Addiction
Lead Sponsor:
Central Institute of Mental Health, Mannheim
Conditions:
Alcohol Use Disorder (AUD)
Eligibility:
All Genders
21-60 years
Phase:
NA
Brief Summary
The project is geared towards the understanding of how to increase cognitive control over cue reactivity and drug craving.
Detailed Description
Project C04 aims at assessing the combined effect of two interventions targeting at reducing striatal cue reactivity and increasing cognitive control, namely mindfulness-based intervention and real-ti...
Eligibility Criteria
Inclusion
- alcohol use disorder according to DSM-5
- ability to provide fully informed consent and to use self-rating scales
- abstinent after detoxification for at least 5 days
- sufficient understanding of the German language
Exclusion
- lifetime history of DSM-5 bipolar, psychotic disorder, or substance dependence other than alcohol or nicotine dependence
- current substance use other than nicotine and/or mild to moderate recreational use of cannabis as evidenced by positive urine test
- current threshold DSM-5 diagnosis of any of the following disorders: current (hypo)manic episode, major depressive disorder, generalized anxiety disorder, PTSD, borderline personality disorder, or obsessive compulsive disorder
- history of severe head trauma or other severe central neurological disorders (dementia, Parkinson's disease, multiple sclerosis)
- pregnancy or nursing infants
- use of medications or drugs known to interact with the CNS within the last 10 days, with testing at least four half-lives post last intake
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04366505
Start Date
July 1 2021
End Date
June 30 2023
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinische Psychologie + Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit
Mannheim, Baden-Wurttemberg, Germany, 68159